HLS Therapeutics (HLS) Insider Trading & Ownership C$5.07 +0.07 (+1.40%) As of 12:37 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock HLS Therapeutics (TSE:HLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.37%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)C$13.11KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)C$1.66K Get HLS Insider Trade Alerts Want to know when executives and insiders are buying or selling HLS Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HLS Insider Buying and Selling by Quarter HLS Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/18/2025Dawn EdinboroSenior OfficerBuy100C$4.95C$495.0012/24/2024Norma BeauchampDirectorBuy500C$3.91C$1,957.0012/12/2024John Lee Welborn Jr.DirectorBuy2,100C$3.25C$6,825.0011/14/2024Norma BeauchampDirectorSell500C$3.31C$1,655.008/14/2024John Gordon HannaDirectorBuy1,200C$3.19C$3,828.00 (Data available from 1/1/2013 forward) HLS Insider Trading Activity - Frequently Asked Questions Who is on HLS Therapeutics' Insider Roster? The list of insiders at HLS Therapeutics includes Brian Thomas Walsh, Craig Millian, Dawn Edinboro, John Gordon Hanna, John Lee Welborn Jr., Norma Beauchamp, Polar Asset Management Partners Inc., and Tim Hendrickson. Learn more on insiders at HLS. What percentage of HLS Therapeutics stock is owned by insiders? 0.37% of HLS Therapeutics stock is owned by insiders. Learn more on HLS's insider holdings. Which HLS Therapeutics insiders have been buying company stock? The following insiders have purchased HLS shares in the last 24 months: Brian Thomas Walsh (C$2,910.00), Craig Millian (C$20,250.00), Dawn Edinboro (C$495.00), John Gordon Hanna (C$3,828.00), John Lee Welborn Jr. (C$6,825.00), Norma Beauchamp (C$1,957.00), and Polar Asset Management Partners Inc. (C$86,000.00). How much insider buying is happening at HLS Therapeutics? Insiders have purchased a total of 32,400 HLS shares in the last 24 months for a total of C$122,265.00 bought. Which HLS Therapeutics insiders have been selling company stock? The following insider sold HLS shares in the last 24 months: Norma Beauchamp (C$1,655.00). How much insider selling is happening at HLS Therapeutics? Insiders have sold a total of 500 HLS Therapeutics shares in the last 24 months for a total of C$1,655.00 sold. HLS Therapeutics Key ExecutivesMr. Craig Stuart Millian M.B.A. (Age 56)CEO & Director Compensation: $941.87kMr. John Hanna C.P.A. (Age 59)CGA, M.B.A., Interim CFO & Non-Independent Director Compensation: $42.34kDr. Jason A. Gross Pharm.D. (Age 59)Vice President of Scientific Affairs Compensation: $361.8kMr. Ryan C. Lennox B.A. (Age 43)J.D., Senior VP of Legal, HR & Compliance and Corporate Secretary Compensation: $434.18kMr. Brian T. WalshSenior Vice President of CommercialMr. David Spence (Age 56)VP & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies ACB Insider Ownership OGI Insider Ownership WEED Insider Ownership CPH Insider Ownership RX Insider Ownership CRDL Insider Ownership MDP Insider Ownership DB Insider Ownership WLLW Insider Ownership CTX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (TSE:HLS) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access